Thermo Fisher Scientific Life Sciences Solutions — Segment assets decreased by 3.0% to $3.45B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.6%, from $2.98B to $3.45B.
An increase suggests capital expansion or investment in segment-specific infrastructure, while a decrease may indicate asset divestiture or improved capital efficiency.
This metric represents the total book value of assets specifically allocated to the Life Sciences Solutions operating se...
Comparable to segment-specific asset bases reported by diversified life science and biotechnology tool providers.
tmo_segment_life_sciences_solutions_segment_assets| Q4 '23 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $3.19B | $3.21B | $2.98B | $3.55B | $3.45B |
| QoQ Change | — | +0.8% | -7.1% | +19.1% | -3.0% |
| YoY Change | — | — | -6.4% | +10.6% | +15.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.